Overdiagnosis in organised mammography screening in Denmark. A comparative study

BMC Women's Health

Volumn 9, Issue , 2009, Pages

  Jørgensen, Karsten J ^a   Zahl, Per Henrik ^b   Gøtzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; DENMARK; DIAGNOSTIC ERROR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; OVERDIAGNOSIS; WOMEN'S HEALTH; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; INCIDENCE; LABORATORY DIAGNOSIS; MASS SCREENING; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; DENMARK; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; RISK FACTORS; WOMEN'S HEALTH;

EID: 74549138493     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-9-36     Document Type: Article

References (25)

1. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer 2003, 3:243-52. 10.1038/nrc1041, 12671663.
2. Vainio H, Bianchini F. IARC Handbooks of Cancer Prevention. Breast Cancer Screening 2002, 7. Lyon; IARC Press.
3. Fryback DG, Stout NK, Rosenberg MA, et al. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 2006, 36:37-47.
4. Zahl PH, Mæhlen J, Welch GH. The natural history of breast cancer detected by screening mammography. Arch Intern Med 2008, 168:2311-2316. 10.1001/archinte.168.21.2311, 19029493.
5. Welch GH. Should I be tested for cancer? 2004, Berkeley and Los Angeles, California; University of California Press, Ltd.
6. Slaytor EK, Ward JE. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. BMJ 1998, 317:263-4. 28619, 9677220.
7. Croft E, Barratt A, Butow P. Information about tests for breast cancer: what are we telling people?. J Fam Pract 2002, 51:858-60.
8. Jørgensen KJ, Gøtzsche PC. Content of invitations for publicly funded screening mammography. BMJ 2006, 332:538-41. 10.1136/bmj.332.7540.538, 1388137, 16513713.
9. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006, (4):CD001877.
10. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends. BMJ 2009, 339:b2587. 10.1136/bmj.b2587, 2714679, 19589821.
11. Boer R, Warmerdam P, de Koning H, van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet 1994, 343(979).
12. NHS Health and Social Care Information Centre Breast Screening Program, England: 2004-05. ISBN: 1-84636-038-2. Accessed on October 15th 2007., NHS Health and Social Care Information Centre., http://www.cancerscreening.nhs.uk/breastscreen/breast-statistics-bulleti n-2004-05.pdf
13. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK, . eds SEER Cancer Statistics Review, 1975-2004. 2007, National Cancer Institute, Bethesda, MD, Based on November 2006 SEER data submission, posted to the SEER web site. Acessed on October 15th 2007., eds., http://seer.cancer.gov/csr/1975_2004/
14. Statistics Denmark Accessed on February 4, 2008., Statistics Denmark., http://www.statistikbanken.dk
15. Danish National Board of Health Early detection and treatment of breast cancer: Status report. Copenhagen 1997, Danish National Board of Health.
16. Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol 2006, 21:203-9. 10.1007/s10654-006-0002-1, 16547835.
17. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E. Breast Cancer Incidence after the Introduction of Mammography Screening - What Should Be Expected?. Cancer 2006, 106:1883-90. 10.1002/cncr.21823, 16572411.
18. Jensen A, Olsen AH, von Euler-Chelpin M, Njor SH, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere?. Int J Cancer 2005, 113:464-70. 10.1002/ijc.20604, 15455383.
19. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005, 117:842-7. 10.1002/ijc.21228, 15957172.
20. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH. Complexities in estimation of overdiagnosis in breast cancer screening. Br J Cancer 2008, 10.1038/sj.bjc.6604638.
21. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-65. 10.1016/S1470-2045(05)70251-5, 16054566.
22. Biesheuvel C, Barratt A, Howard K, Houssami N. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007, 8:1129-38. 10.1016/S1470-2045(07)70380-7, 18054882.
23. Olsen AH, Jensen A, Njor S, Villadsen E, Schwartz W, Vejborg I, Lynge E. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003, 88:362-65. 10.1038/sj.bjc.6600712, 2747539, 12569377.
24. Törnberg S, Kemetli L, Lynge E, Olsen AH, Hofvind S, Wang H, Anttila A, Hakama M, Nyström L. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol 2006, 45:528-35. 10.1080/02841860500501610, 16864165.
25. Gøtzsche PC, Hartling OJ, Nielsen M, Jørgensen KJ, Brodersen J. Breast Screening - The Facts. Or maybe not. BMJ 2009, 338:446-8.